Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial

被引：0
|
作者：
P-L Jerevall
X-J Ma
H Li
R Salunga
N C Kesty
M G Erlander
D C Sgroi
B Holmlund
L Skoog
T Fornander
B Nordenskjöld
O Stål
机构：
[1] Faculty of Health Sciences,Department of Clinical and Experimental Medicine, Division of Oncology
[2] Linköping University,Department of Pathology
[3] bioTheranostics,Department of Oncology
[4] 9640 Towne Centre Dr Suite 200,Department of Pathology and Cytology
[5] Molecular Pathology Research Unit,undefined
[6] Massachusetts General Hospital,undefined
[7] Karolinska University Hospital,undefined
[8] Stockholm South General Hospital,undefined
[9] Karolinska University Hospital,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
Breast Cancer Index; recurrence; risk assessment; gene expression profiling; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1762 / 1769
页数：7
相关论文
共 50 条
  • [1] Prognostic utility of HOXB13: IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
    Jerevall, P-L
    Ma, X-J
    Li, H.
    Salunga, R.
    Kesty, N. C.
    Erlander, M. G.
    Sgroi, D. C.
    Holmlund, B.
    Skoog, L.
    Fornander, T.
    Nordenskjold, B.
    Stal, O.
    BRITISH JOURNAL OF CANCER, 2011, 104 (11) : 1762 - 1769
  • [2] Validation of Prognostic Utility of HOXB13:IL17BR and Molecular Grade Index in Early Stage Breast Cancer
    Stal, O.
    Jerevall, P-L
    Ma, X-J
    Li, H.
    Salunga, R.
    Erlander, M.
    Sgroi, D.
    Holmlund, B.
    Skoog, L.
    Fornander, T.
    CANCER RESEARCH, 2009, 69 (24) : 504S - 504S
  • [3] Prognostic Utility of HOXB13:IL17BR and Molecular Grade Index for Node-Negative Breast Cancer Patients
    Habel, L.
    Erlander, M.
    Achacoso, N.
    Ma, X-J
    Sgroi, D.
    Fehrenbacher, L.
    Greenberg, D.
    Quesenberry, C.
    CANCER RESEARCH, 2009, 69 (24) : 717S - 717S
  • [4] A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer
    Ma, Xiao-Jun
    Salunga, Ranelle
    Dahiya, Sonika
    Wang, Wilson
    Carney, Erin
    Durbecq, Virginie
    Harris, Adrian
    Goss, Paul
    Sotiriou, Christos
    Erlander, Mark
    Sgroi, Dennis
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2601 - 2608
  • [5] The HOXB13:IL7BR expression index is a prognostic factor in early-stage breast cancer
    Ma, Xiao-Jun
    Hilsenbeck, Susan G.
    Wang, Wilson
    Ding, Li
    Sgroi, Dennis C.
    Bender, Richard A.
    Osborne, C. Kent
    Allred, D. Craig
    Erlander, Mark G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) : 4611 - 4619
  • [6] The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer
    Wang, Zuncai
    Dahiya, Sonika
    Provencher, Heather
    Muir, Beth
    Carney, Erin
    Coser, Kathryn
    Shioda, Toshi
    Ma, Xiao-Jun
    Sgroi, Dennis C.
    CLINICAL CANCER RESEARCH, 2007, 13 (21) : 6327 - 6334
  • [7] HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
    Habel, Laurel A.
    Sakoda, Lori C.
    Achacoso, Ninah
    Ma, Xiao-Jun
    Erlander, Mark G.
    Sgroi, Dennis C.
    Fehrenbacher, Louis
    Greenberg, Deborah
    Quesenberry, Charles P., Jr.
    BREAST CANCER RESEARCH, 2013, 15 (02)
  • [8] HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease
    Laurel A Habel
    Lori C Sakoda
    Ninah Achacoso
    Xiao-Jun Ma
    Mark G Erlander
    Dennis C Sgroi
    Louis Fehrenbacher
    Deborah Greenberg
    Charles P Quesenberry
    Breast Cancer Research, 15
  • [9] Breast cancer index and assessment of tumor proliferation by molecular grade index (MGI) within distinct HOXB13/IL17BR (H/I) subsets
    Mahtani, Reshma
    Yuan, Yuan
    Wisinski, Kari B.
    Morris, Jay
    Salganik, Max
    Zhang, Yi
    Schnabel, Catherine A.
    Gadi, Vk
    CANCER RESEARCH, 2022, 82 (04)
  • [10] Prediction of the clinical benefit of adjuvant tamoxifen therapy using Breast Cancer Index (HOXB13:IL17BR)
    Zhang, Yi
    Schroeder, Brock E.
    Jerevall, Piiha-Lotta
    Stal, Olle
    Sgroi, Dennis C.
    Erlander, Mark G.
    Schnabel, Catherine A.
    MOLECULAR CANCER RESEARCH, 2013, 11
12345